Condensed Consolidated Statements of Operations - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Condensed Consolidated Statements of Operations [Abstract]
Net sales		$ 1,010,900	$ 1,071,300	$ 2,618,300	$ 3,379,600
Operating costs and expenses
Cost of revenue		123,300	41,300	252,900	123,800
Research and development	[1]	3,893,700	2,202,700	41,913,900	7,212,200
Sales and marketing	[1]	2,189,400	333,600	4,435,100	978,100
General and administration	[1]	17,697,000	1,509,000	95,910,700	5,666,700
Depreciation and amortization	[1]	762,200	14,700	771,500	47,600
Total costs and operating expenses	[1]	24,665,600	4,101,300	143,284,100	14,028,400
Loss from operations		(23,654,700)	(3,030,000)	(140,665,800)	(10,648,800)
Interest income		4,653,000	0	6,814,500	0
Interest expense		(246,700)	(15,071,900)	(2,906,500)	(37,702,500)
Change in fair value of derivative liabilities		0	(7,931,200)	(225,916,000)	(660,200)
Loss on the conversion of convertible debt		0	0	(542,300)	0
Loss from operations before income taxes		(19,248,400)	(26,033,100)	(363,216,100)	(49,011,500)
Income tax expense		0	0	0	0
Net loss		$ (19,248,400)	$ (26,033,100)	$ (363,216,100)	$ (49,011,500)
Loss per Share attributable to common stockholders:
Basic (in dollars per share)		$ (0.1)	$ (0.3)	$ (2.37)	$ (0.56)
Diluted (in dollars per share)	[2]	$ (0.1)	$ (0.3)	$ (2.37)	$ (0.56)
Weighted Average Shares used to compute net loss per share attributable to common stockholders:
Basic (in shares)		200,833,835	87,500,000	152,943,536	87,500,000
Diluted (in shares)		200,833,835	87,500,000	152,943,536	87,500,000

[1] Costs of operating expenses include stock-based compensation expense as follows:

[2] Loss per share attributable to common stockholders for diluted calculation is based on the Basic weighted shares as these are not dilutive. The Basic and diluted loss per share attributable to common stockholders are therefore the same.